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At the 48th Annual Drosophila Research Conference in Philadelphia, work was 
presented on multiple aspects of host-microbe interactions. This included identifying 
new components of known immune signaling pathways—IMD, Toll and JAK/STAT; 
studies of wounding and cellular responses; exploring pathogenesis with established 
models (Pseudomonas, Salmonella, Plasmodia, parasitoid wasps) and establishing new 
models; identification of bacterial species that infect Drosophila in the wild; and using the 
organism to understand the physiology of the immune response. 
NeW compoNeNtS of immuNe SigNaLiNg pathWayS
This work was gratifying as it begins to provide validation in vivo for some of the 
genes identified in cell-based high-throughput RNAi screens. These screens have used the 
expression of reporter genes for the IMD, Toll, and JAK/STAT signaling pathways. David 
Kuttenkeuler (Michael Boutros’ lab, German Cancer Research Center) reported a novel 
Toll pathway regulator, DEAF1 (deformed epidermal autoregulatory factor 1). DEAF1 
is a DNA binding protein that appears to act downstream of Cactus (IκB homolog) and 
Dif and Dorsal (NF-κB homologs). In S2 cells, RNAi against Cactus results in increased 
Drosomycin (Toll pathway target gene) expression that can be suppressed by RNAi of 
DEAF1. Similarly, overexpression of Dif or Dorsal leads to expression of Drosomycin, 
which can be partially suppressed by DEAF1 RNAi. Expression of a transgenic DEAF1 
hairpin in vivo resulted in flies that are impaired in their expression of Drosomycin in 
response to Micrococcus luteus infection. It will be interesting to determine if DEAF1-RNAi 
flies are also more susceptible to fungal or Gram-positive bacterial infection. Nadege Pelte 
(also of the Boutros lab) described the identification of Chifoumi, a putative secreted 
factor and new negative regulator of the JAK/STAT pathway. Chifoumi is upregulated 
following a mixed bacterial infection. Overexpression of Chifoumi can block activation of 
the JAK/STAT pathway in vitro and in vivo. It will be interesting to see the phenotypes 
of the Chifoumi mutant and how failure to downregulate the JAK/STAT pathway 
might result in developmental and immune defects. Dominique Ferrandon (CNRS; in 
 collaboration with Neal Silverman, UMass Medical School) described characterization 
of TAB2 (TAK1-associated binding protein 2; also known as TAB, CG7417 or galère) 
mutants and their effect in the IMD pathway. Previously, TAB2 was identified in S2 cells 
as necessary for induction of the IMD pathway1.2 TAB2 was also shown to function with 
dTAK1 to activate the JNK signaling and cell death downstream of the TNF homolog 
eiger.3 The IMD pathway also activates JNK signaling, and dTAK1 is required for both 
NF-κB and JNK activation in this pathway.4 In this new presentation, Ferrandon showed 
that two TAB2 isoforms (long and short) were differentially required for JNK and NF-κB 
signaling. Molecular and phenotypic analysis of the TAB2 mutant alleles indicated that 
the long form is required only for the activation of the JNK pathway and is not required 
for resistance to infection. A TAB2 mutation that affects both long and short forms is 
 susceptible to E. coli infection and fails to activate the NF-κB homolog Relish and the 
expression of antimicrobial peptide genes. Thus, JNK signaling (downstream of dTAK) 
does not appear to be required for antimicrobial peptide gene expression and may be 
dispensable for the protection against certain infections. However, reports from others (see 
below) would argue that the JNK arm of the pathway is essential in mediating protection 
against other types of infections (Pseudomonas, Salmonella). It will be interesting to test 
whether the TAB2-long mutants are more susceptible in those infection models. Francois 
Leulier (from Pascal Meier’s lab, Institute for Cancer Research) presented new data on 
diap2 (Drosophila Inhibitor of apoptosis 2) and its role in the IMD pathway. DIAP2 was 
previously identified in cell-based RNAi screens as a component of the IMD pathway.1,5 
Characterization of diap2 mutants in vivo indicated that diap2 was not necessary to 
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prevent most apoptosis, but was important for IMD signaling. diap2 
mutants failed to induce IMD target genes and were more susceptible 
to infection by the Gram-negative bacteria Erwinia carotovora.6,7 
While diap2 transgenes with point mutations in individual BIR 
domains complemented, RING finger mutant versions of diap2 
failed to rescue the immune deficient phenotype, indicating that the 
RING ubiquitin-ligase domain is essential for IMD signaling. 
Similar results have been reported by Bruce Hay’s group,7 who also 
reported that diap2 may be important for promoting cleavage of 
Relish (NF-κB factor in the IMD pathway) and that expression of 
cell death-inducing genes, reaper or Hid, leads to a downregulation of 
DIAP2. This suggests that cell death events may be able to influence 
the IMD pathway via DIAP2.
heaLiNg the WouNd
At the site of injury, epithelial cells activate JNK signaling, 
presumably to trigger tissue repair, and blood cells secrete factors 
to mediate clotting and melanization at the wound site.8,9 Huaping 
Tang (in Carl Hashimoto’s lab, Yale University working with Bruno 
Lemaitre’s group, CNRS) presented an RNAi screen looking at the 
function of 18 serpin-type inhibitors in vivo. They had previously 
identified two serine proteases, MP1 and MP2, important for the 
melanization response,10 so this RNAi screen could potentially 
identify the inhibitors for these proteases. He found that many 
serpins are essential (nine of the 18 are lethal when the hairpin 
RNAi is expressed via an actin-GAL4). RNAi of 10 of the serpins 
resulted in constitutive melanization, and RNAi of seven resulted in 
constitutive Drosomycin expression. The phenotypes were not easily 
categorized, as the various serpins RNAi lines showed some or all of 
the phenotypes (lethality, melanization, and Drosomycin expression). 
One serpin of interest, Spn77Ba (CG6680), was lethal and showed 
constitutive melanization in the trachea. The melanization and 
lethality could be suppressed by a mutation in MP1—suggesting that 
unregulated activation of MP1 can be lethal and that Spn77Ba might 
be its inhibitor. Gawa Bidla (in Ulrich Theopold’s lab, University 
of Stockholm) explored the role of melanization in formation of 
the clot at a wound site.11 He showed that crystal cells rupture 
and release prophenoloxidase resulting in melanization of the clot 
matrix. By screening for failure to either rupture the crystal cells or 
induce melanization, he found that eiger (TNF ligand) and the JNK 
pathway are necessary and that hemocytes in the clot show hallmarks 
of apoptosis. Suppression of this apoptosis (by expression of the viral 
apoptosis inhibitor p35) resulted in reduction of clot melanization. 
He was able to nicely mimic this with ectopic induction of apoptosis 
in hemocytes resulting in melanization. This indicates that the JNK 
pathway and induction of hemocyte apoptosis are important for 
 triggering the melanization of the clot.
ceLLuLar immuNe reSpoNSe, roLe of the toLL pathWay
Nina Matova (in Kathryn Anderson’s lab, MSKCC) reported on 
the roles for Dif and Dorsal in the cellular immune response.12 The 
 hemolymph of Dif dorsal double mutant larvae is filled with microbes 
and has reduced numbers of hemocytes. These hemocytes were able 
to engulf bacteria, but were unable to clear them. This overwhelming 
bacterial infection is the likely cause of the larval lethality, as 
 antibiotic treatment resulted in improved hemocyte morphology 
and greater numbers of animals surviving to adulthood. Expression 
of either dorsal or Dif in the hemocytes rescued all the observed 
phenotypes. Expression of either dorsal or Dif in fat body also rescued 
the numbers of hemocytes, suggesting that a factor from the fat 
body can influence hemocyte survival. The reduction in hemocyte 
numbers in the double mutant appears to be due to increased cell 
death. Expression of dIap1 (Drosophila inhibitor of apoptosis 1) in 
the hemocytes increased the hemocyte numbers and improved the 
numbers of double mutant animals surviving to adulthood (from 
6.7 to 38.5%). The inability to clear microbes from the hemocytes 
may cause those cells to die; alternatively or additionally, Dif and 
Dorsal may be acting to inhibit programmed cell death. Work 
reported by Jinu Abraham (in Soichi Tanda’s lab, Ohio University) 
also supported the model of Toll pathway components influencing 
hemocyte numbers and survival. Mutations in lesswright (Ubc9 
homolog; SUMO conjugating enzyme) result in activation of the 
Toll pathway.13 lesswright mutants show high numbers of hemocytes 
and melanotic masses, a phenotype similar to loss of function 
 mutations in cactus (IκB homolog). A lesswright cactus double mutant 
resulted in fewer blood cells. This decrease in blood cells is likely due 
to increased apoptosis, as assayed with acridine orange staining of the 
cells. It is curious that these two mutations, that both lead to the Toll 
pathway activation, result in a phenotype similar to the Dif dorsal 
double mutant, which has no Toll signaling. The apoptosis may be 
occurring via activation of the JNK pathway, as a lesswright, JNK 
dominant negative double ‘mutant’ displayed increased numbers of 
hemocytes and decreased apoptosis. Michaela Fenckova (in Tomas 
Dolezal’s lab, University of South Bohemia) presented evidence that 
increased amounts of adenosine (a nucleotide metabolite) in the 
hemolymph contribute to the formation of melanotic tumors and 
lethality in activated Toll pathway mutants.13 ADGF-A (adenosine 
deaminase) is an enzyme that degrades adenosine, keeping levels of 
extracellular adenosine low. The ADGF‑A mutation is larval lethal, 
with the mutant larvae showing high levels of adenosine in their 
hemolymph, disintegrating fat body tissue, and melanotic tumors. 
Aspects of the ADGF‑A phenotype are similar to that of cactus (or 
activation of the Toll pathway). They find that overexpression of 
ADGF‑A can suppress melanotic tumors and partially rescue cactus 
lethality. This suggests that adenosine signaling is downstream 
of Toll signaling and that adenosine may serve as an endogenous 
danger signal.
expLoriNg pathogeNeSiS aNd NeW modeLS  
of microbiaL iNfectioN
New data was presented using Drosophila to dissect mechanisms 
of microbial pathogenesis. For Salmonella, Rheinallt Jones (Andrew 
Neish’s lab, Emory University) used transgenic expression of the 
type III effector virulence gene AvrA to find that it suppresses 
dTAK1, a critical component in IMD-induced NF-κB and JNK 
pathways. Expression of AvrA in the fat body led to inhibition of 
Diptericin expression and increased susceptibility to infection by 
the Gram-negative bacteria E. coli and Erwinia caratovora. In the 
Drosophila eye, expression of AvrA suppressed the small and rough 
eyes caused by overexpression of dTAK1 or eiger. This suggested 
that AvrA was acting at the level of, or downstream of dTAK1. 
He reported that expression of AvrA resulted in inhibition of JNK 
 phosphorylation in the larval fat body. The model presented suggests 
that AvrA from the Salmonella results in inhibition of JNK-mediated 
immune and/or apoptotic responses, although it is possible that AvrA 
also inhibits Relish activation. It will be important to confirm this role 
for AvrA by infecting flies with wildtype and avrA mutant Salmonella. 
Yiorgos Apidianakis (Laurence Rahme’s lab, Massachusetts General 
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Hospital) found that JNK signaling is also important for response 
to a local infection with Pseudomonas aeroginosa. He found that 
the route of infection influences the host defense responses to the 
pathogen: infection by pricking the thorax with a bacterial-laden 
needle caused a local infection, while microinjection of bacteria led 
to a systemic infection. In the field, labs are split in their preference 
for thorax pricking vs. microinjection into the abdomen—these data 
suggest (at least for Pseudomonas infection) that the infections and 
immune responses will differ according to the route of inoculation. 
Local (thorax) infections modulated muscle gene expression via 
JNK signaling and this interaction may be key for P. aeruginosa 
virulence. Roberto Ferrarese and Angel Tibbs (Shubha Govind’s 
lab, CUNY) presented data on the interaction between parasitoid 
wasps (avirulent Asobara tabida, and virulent Leptopilina boulardi‑17 
and L. heterotoma‑14) and the Drosophila immune response. The 
immune response to wasp eggs is primarily driven by a cellular 
response, with specialized blood cells, lamellocytes, that encapsulate 
the egg. They found that the Toll and IMD pathways are activated 
and up-regulated by avirulent A. tabida or virulent L. bourlardi 
infection. In contrast, virulent L. heterotoma do not induce these 
humoral responses. The eggs from the two virulent wasp strains are 
not encapsulated. The parasitoid wasp infection provides a natural 
system to study the potential coordination between humoral and 
cellular immune responses, although it is still very unclear if there is 
any causal relationship. 
Alison Fedrow (Keith Chapes’ lab, Kansas State University) makes 
use of S2 cells as a model for mammalian macrophages. She found 
that Ehrlichia chafeensis, an obligate intracellular bacteria that causes 
human monocytic ehrlichiosis, can propagate in S2 cells and remain 
infectious to mammalian macrophages. She plans to identify genes 
important for pathogenesis through RNAi and microarray analyses. 
Along the lines of the fly as a model mosquito, Robert Glaser 
(Wadsworth Center, NY State Department of Health) showed data 
indicating that Drosophila can be infected with West Nile Virus 
(WNV). WNV is an RNA virus that is carried by mosquitoes and 
birds, and can cause fever-like symptoms in humans. WNV infection 
is not lethal to Drosophila, so the viral infection was assayed by 
titering viral loads. He presented data indicating that an RNAi 
response is induced against the virus in S2 cells, and mutations in 
the RNAi pathway (piwi, spindle‑E) lead to much higher titers of the 
virus in the fly. This shows the importance of RNAi against West 
Nile, at least in flies, but also establishes Drosophila as a viable system 
to identify genes important for susceptibility to WNV in mosquitoes. 
The power of this approach was demonstrated by Hirotaka Kanuka 
(Obihiro University, Japan; in collaboration with David Schneider, 
Stanford University) with their use of Drosophila as a host for 
Plasmodia parasites, the causative agents for malaria. From a screen 
in Drosophila, they identified a C-type lectin, furrowed (CG1500) as 
important for the response to P. gallinaceum. They present data that 
RNAi of furrowed in Anopheles gambiae, the vector for the human 
malarial pathogen P. falciparum, leads to increased P. berghei oocysts 
in the mosquito midgut. Furrowed may represent an important 
receptor for containing Plasmodia infection in the insect. As such, it 
may provide a target for manipulating the ability of the mosquito to 
transmit Plasmodia. 
out of the Lab, iNto the WiLd
Several presentations focused on identifying bacteria that naturally 
infect flies. Punita Juneja (Brian Lazzaro’s lab, Cornell University) 
captured Drosophila in New York State, then cultured bacteria from 
the hemolymph of these wild flies and used nested PCR for 16S 
rDNA to identify bacterial species. She found that the frequency of 
infection was low (1–2.5%) suggesting that flies in the wild can clear 
most infections that are not rapidly lethal. The bacteria identified 
from wild Drosophila included many Staphylococcus strains and a 
lot of soil microbes like Serratia and Pseudomonas, that are linked 
to opportunistic infections in humans. When cultured, most of 
the identified bacterial strains were not lethal to Oregon R flies. 
One exception (in work presented by Madeline Galac, also of the 
Lazzaro lab) was new Providencia species, a Gram-negative bacteria, 
that caused 100% mortality within five days. Infection of flies with 
this Providencia also led to decreased antimicrobial peptide gene 
 induction, relative to other infections, suggesting that this microbe 
may be suppressing or evading the immune response. Vanessa 
Corby-Harris (Daniel Promislow’s lab, University of Georgia) took 
a similar approach. In this case, ten populations of flies were 
collected along the East Coast and 16S bacterial rDNA from the 
fly was cloned and sequenced. Using total fly extracts should also 
identify bacteria present in the fly gut. This approach enabled her 
to characterize aspects of each populations’ immune responses and 
determine if this could be correlated with having a diverse bacterial 
flora. She found that there were lots of γ-proteobacteria (i.e. 
Salmonella and Pseudomonas) in the flies. She also found that these 
10 populations were variable in their resistance to infection with 
Pseudomonas aeroginosa and Lactococcus lactis. She found that there 
was no correlation with ability to withstand Lactococcus infection 
and microbial richness, but that resistance to Pseudomonas correlated 
with increased microbial richness. It will be interesting to determine 
whether this resistance to Pseudomonas is mediated by the presence 
of the diverse microbial flora, or if both the flora presence and 
Pseudomonas resistance is due to differences in the immune responses 
of the different fly populations. 
goiNg phySioLogicaL (aNd uSiNg the orgaNiSm  
to diScover NeW thiNgS)
Several very interesting presentations at the meeting came from 
studies asking different questions about how the fly deals with 
infection. Linh Pham (David Schneider’s lab, Stanford University) 
described the discovery of an adaptive or priming response in 
Drosophila.14 This is dogma challenging, as innate immunity is often 
defined as not being adaptive. She found that if flies were primed 
with a non-lethal dose of Streptococcus pneumoniae, this could protect 
against a later lethal dose of same bacteria. This priming response 
was specific, as other pathogenic microbes could not substitute for 
either the priming or the lethal dose. The ability to specifically prime 
and prevent a later lethal dose was also seen with infection with the 
entomopathogenic fungi, Beauvaria bassiana. This suggests that 
the ability to adapt may be a generally important innate immune 
response to pathogenic microbes. This response was not dependent 
on an antimicrobial peptide response, but was dependent on the 
hemocytes. The data presented also indicated that the Toll pathway 
and the JAK/STAT signaling may play roles in this priming response. 
Mimi Shirasu-Hiza (also of the Schneider lab) presented an engaging 
talk on the relationship between infection and circadian rhythms. She 
found that following a pathogenic infection, flies lose their circadian 
rhythm and get less sleep. Is losing rhythm helpful in fighting an 
infection? She found that circadian rhythm mutants, period or 
 timeless, are more susceptible to Streptococcus pneumoniae and Listeria 
 monocytogenes, but more resistant to Burkholderia cepacia. If the 
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 wildtype flies are infected with a non-lethal dose of S. pneumoniae, 
they lose their rhythm initially, but upon clearing the infection, 
they can regain their rhythm. This brings up intriguing questions of 
how our immune system might affect our behavior and vice versa. 
Definitely something to think about next time you can’t sleep—
maybe it’s an infection that’s keeping you up and not worries about 
getting that grant funded. 
coNcLudiNg remarKS
The immunology and pathogenesis research presented at this year’s 
Drosophila Research Conference spanned a wide breadth of topics. 
Work continues on the IMD and Toll pathways, focusing evermore 
on the molecular mechanisms involved in signal transduction. New 
roles for the Drosophila NF-κB homologs in the development of 
hemocytes and in cellular immunity were described. New models of 
microbial pathogenesis, with a variety of microbes, were presented, 
leading to new and surprising insights. And, new natural bacterial 
pathogens of flies were reported. Overall, this is an exciting time 
in the field—the foundations of Drosophila immunity, discovered 
by focusing on the response to few select microbes, are now being 
applied to more challenging questions, detailing host-pathogens 
interactions. The host’s response to pathogens, and the microbes 
counter-responses, are being elucidated. In addition, field studies are 
probing how populations change in response to different pathogen 
burdens. All these approaches, each of which takes advantage of some 
of the unique and powerful experimental attributes of Drosophila 
research, will continue to contribute to this fast moving field.
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